01524nam a2200313Ia 4500001001200000003000800012005001700020006001900037007001500056008004100071020001500112020001800127040002100145035002100166050002500187110012300212245032200335260005600657300001400713504004100727533015200768650003700920650002200957650002700979650002701006655002901033710001701062856013101079ebr10237094CaPaEBR20260707180647.0m        u        cr cn|||||||||080521s2008    dcu     sb    000 0 eng d  z0309118662  z9780309118668  aCaPaEBRcCaPaEBR  a(OCoLC)64675597614aRA644.I6bI56 2008eb2 aInstitute of Medicine (U.S.).bCommittee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic.10aAntivirals for pandemic influenzah[electronic resource] :bguidance on developing a distribution and dispensing program /cCommittee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.  aWashington, DC :bNational Academies Press,cc2008.  ax, 122 p.  aIncludes bibliographical references.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntiviral agentsxEffectiveness. 0aAntiviral agents. 0aEpidemicsxPrevention. 0aInfluenzaxPrevention. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/strathmore/Doc?id=10237094zAn electronic book accessible through the World Wide Web; click to view